PAT-SM6

· Patrys Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PAT-SM6, covering 2015-10-22 to 2015-10-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Preliminary Efficacy Study of the Antibody PAT-SM6 in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]

See pricing